Matches in Wikidata for { <http://www.wikidata.org/entity/Q89946899> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q89946899 description "article scientifique publié en 2020" @default.
- Q89946899 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89946899 description "scientific article published on 28 February 2020" @default.
- Q89946899 description "wetenschappelijk artikel" @default.
- Q89946899 description "наукова стаття, опублікована 28 лютого 2020" @default.
- Q89946899 name "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting respon" @default.
- Q89946899 name "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting respon" @default.
- Q89946899 type Item @default.
- Q89946899 label "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting respon" @default.
- Q89946899 label "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting respon" @default.
- Q89946899 prefLabel "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting respon" @default.
- Q89946899 prefLabel "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting respon" @default.
- Q89946899 P1433 Q89946899-CDA60961-CC79-460B-BAA0-6BD735FF3323 @default.
- Q89946899 P1476 Q89946899-D53A4949-5D71-4242-A8CF-61EE2BA7E086 @default.
- Q89946899 P2093 Q89946899-99AF3FD0-6AEA-4BCC-ADC5-BF7B443D99E9 @default.
- Q89946899 P2093 Q89946899-D6775BAF-D185-4DE2-9DBE-781DC62258CE @default.
- Q89946899 P31 Q89946899-62EBD73C-5CBF-43CA-A242-634F6E878F68 @default.
- Q89946899 P356 Q89946899-7C3759DE-411A-48A3-B944-8D7875FC32CE @default.
- Q89946899 P577 Q89946899-F70B94A7-5557-4781-A6C2-B87463EAC947 @default.
- Q89946899 P698 Q89946899-4D23DFEA-B972-4657-8003-B9A99CC76622 @default.
- Q89946899 P921 Q89946899-3E2F3CFB-2BC3-459C-A34A-32D978DFD7E1 @default.
- Q89946899 P356 JNMT.119.235960 @default.
- Q89946899 P698 32111660 @default.
- Q89946899 P1433 Q6295663 @default.
- Q89946899 P1476 "Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (68Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting response to 177Lu-PSMA-617 Radioligand Therapy vis-à-vis conventional risk categories" @default.
- Q89946899 P2093 "Aadil Adnan" @default.
- Q89946899 P2093 "Sandip Basu" @default.
- Q89946899 P31 Q13442814 @default.
- Q89946899 P356 "10.2967/JNMT.119.235960" @default.
- Q89946899 P577 "2020-02-28T00:00:00Z" @default.
- Q89946899 P698 "32111660" @default.
- Q89946899 P921 Q18555107 @default.